Stock listing

NASDAQ:VERU Veru Inc. Stock

Home listing (NASDAQ) of Veru Inc.

Follow Veru Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:VERU

$1.94 USD -0.37 (-16.0%)

Close on Nov 20, 2026

Past year -13.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.93 – $2.17 USDNov 20, 2026
Volume
247,921 sharesNov 20, 2026
Market cap
$33.08M USDAt the close on Nov 20, 2026 · price × 17.05M shares outstanding
52-week range
$1.93 – $7.33 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$468,881 USDMedian day 130,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Veru Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:VERU · Home$1.94 USD-0.37 (-16.0%)247,921$2.09$2.17$1.93$2.31Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:VERU · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.94-0.37-16.0%$2.09$2.17$1.93247,921
$2.31+0.17+7.9%$2.16$2.34$2.13467,111
$2.14+0.06+2.9%$2.09$2.20$2.075305,002
$2.08-0.01-0.5%$2.08$2.14$2.03198,888
$2.09-0.03-1.4%$2.15$2.15$2.0890,524
$2.12-0.02-0.9%$2.10$2.15$2.07991,575
$2.14+0.02+0.9%$2.13$2.17$2.07138,942
$2.12-0.07-3.2%$2.17$2.21$2.06128,464
$2.19+0.07+3.3%$2.12$2.21$2.105134,522
$2.12+0.06+2.9%$2.08$2.15$2.07137,144
$2.06-0.14-6.4%$2.20$2.20$2.04214,771
$2.20+0.04+1.9%$2.18$2.23$2.10180,514
$2.160.000.0%$2.18$2.22$2.11103,489
$2.16-0.03-1.4%$2.20$2.22$2.075249,370
$2.19-0.04-1.8%$2.25$2.26$2.1678,878
$2.23-0.04-1.8%$2.27$2.33$2.2256,935
$2.27-0.01-0.4%$2.27$2.30$2.2473,162
$2.28+0.07+3.2%$2.22$2.34$2.22157,711
$2.21-0.03-1.3%$2.25$2.26$2.1886,578
$2.24-0.05-2.2%$2.29$2.32$2.22122,600
$2.29-0.01-0.4%$2.30$2.30$2.2485,800
$2.30-0.08-3.4%$2.37$2.41$2.2899,800
$2.38+0.07+3.0%$2.31$2.40$2.3189,700
$2.31+0.01+0.4%$2.30$2.35$2.2788,100
$2.30-0.14-5.7%$2.41$2.48$2.27305,400
$2.44+0.31+14.6%$2.14$2.48$2.12505,300
$2.13-0.06-2.7%$2.26$2.29$2.11275,200
$2.19-0.22-9.1%$2.41$2.42$2.18169,200
$2.41-0.05-2.0%$2.44$2.45$2.4085,500
$2.46+0.04+1.7%$2.42$2.49$2.42128,900
$2.42-0.04-1.6%$2.44$2.52$2.39147,600
$2.46-0.01-0.4%$2.42$2.54$2.41202,400
$2.47-0.08-3.1%$2.54$2.75$2.441,517,500
$2.55+0.04+1.6%$2.51$2.62$2.5088,600
$2.51-0.03-1.2%$2.56$2.56$2.50104,900
$2.54-0.12-4.5%$2.65$2.65$2.5370,700
$2.66+0.10+3.9%$2.58$2.70$2.51183,000
$2.56+0.03+1.2%$2.53$2.58$2.5033,100
$2.53-0.01-0.4%$2.52$2.57$2.51101,300
$2.54+0.03+1.2%$2.55$2.57$2.50115,800
$2.51+0.05+2.0%$2.42$2.52$2.4287,400
$2.46-0.04-1.6%$2.49$2.51$2.4394,000
$2.50+0.06+2.5%$2.46$2.52$2.42121,400
$2.44+0.03+1.2%$2.44$2.49$2.43158,200
$2.41+0.02+0.8%$2.39$2.44$2.36102,900
$2.39+0.07+3.0%$2.35$2.40$2.3593,900
$2.32-0.02-0.9%$2.34$2.37$2.31130,300
$2.340.000.0%$2.36$2.36$2.29125,300
$2.34-0.10-4.1%$2.41$2.44$2.34207,500
$2.44-0.06-2.4%$2.52$2.53$2.43239,300
$2.50+0.02+0.8%$2.52$2.53$2.46181,400
$2.48-0.10-3.9%$2.59$2.59$2.48264,800
$2.58-0.06-2.3%$2.81$2.85$2.551,340,500
$2.64-0.01-0.4%$2.65$2.73$2.63143,500
$2.65-0.10-3.6%$2.75$2.77$2.6575,400
$2.75+0.06+2.2%$2.70$2.76$2.65202,600
$2.69-0.11-3.9%$2.80$2.82$2.69203,200
$2.80+0.17+6.5%$2.63$2.83$2.59250,000
$2.63-0.11-4.0%$2.71$2.73$2.6192,700
$2.74-0.06-2.1%$2.82$2.84$2.71122,500
$2.80+0.09+3.3%$2.73$2.82$2.70169,400
$2.71+0.12+4.6%$2.60$2.79$2.60227,020
$2.59-0.05-1.9%$2.64$2.64$2.50102,569
$2.64+0.06+2.3%$2.56$2.68$2.56177,500
$2.58-0.06-2.3%$2.65$2.68$2.52135,400

Splits

1 split · NASDAQ:VERU · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
NASDAQ:VERU
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Veru Inc. news

Veru Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in the last 12 months · 150 in all · newest Nov 17, 2026 · oldest 2019
Calls
19 calls with a replay · 19 with a transcript · latest Aug 10, 2026
Decks
40 decks · latest Nov 16, 2026

Where Veru Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:VERU · Home listing · This pageNASDAQUnited StatesUSD
BOATS:VERUBOATSUnited StatesUSD
gettex:FMW0gettexGermanyEUR
Frankfurt:FMW0FrankfurtGermanyEUR
Lang & Schwarz:A41ES4Lang & SchwarzGermanyEUR
LS Exchange:A41ES4LS ExchangeGermanyEUR
Munich:FMW0MunichGermanyEUR

Valuation

Price/book 1.2× against a median of 1.3×: 5th lowest of 11 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$9.20M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.92

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Veru Inc. · NASDAQ:VERUUS$33.08MUS$9.20Mn/an/an/a1.2×n/a0.0×1.92
Cue Biopharma, Inc. · NASDAQ:CUEUS$34.69M−US$23.25Mn/a−0.7×n/a0.9×−580.0%0.0×2.35
B&K Corporation Limited Class H · HKEX:2396US$33.15M−US$47.10Mn/a−602×n/a0.4×n/a0.0×n/a
Actinium Pharmaceuticals, Inc. (Delaware) · AMEX:ATNMUS$33.01MUS$5.49M3.1×n/a0.6×1.3×n/a0.1×0.71
Neurizon Therapeutics Limited · ASX:NUZUS$32.76MUS$26.54Mn/a2.3×n/a3.9×−61.0%0.3×n/a
CJ Bioscience. Inc. · KRX:311690US$32.52MUS$1.91Mn/a0.7×n/a1.0×−607.2%0.0×n/a
Transcenta Holding Limited · HKEX:6628US$32.41MUS$52.52Mn/a12.4×n/a0.4×−569.5%0.3×n/a
Enimmune Corporation · TPEX:6564US$31.74MUS$26.87Mn/a18.4×n/a10.4×−341.0%0.3×n/a
Molecure SA · GPW:MOCUS$31.66MUS$29.60Mn/an/an/a1.3×n/a0.0×n/a
Sareum Holdings plc · LSE:SARUS$31.03MUS$27.78Mn/an/an/a19.9×n/a0.0×n/a
Isofol Medical AB · OMXSTO:ISOFOLUS$31.03MUS$19.80Mn/an/an/a3.3×n/a0.0×n/a
Median of the othersUS$32.46MUS$23.17M3.1×1.5×0.6×1.3×−569.5%0.0×1.53

Forecasts

3 strong buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
25.67 USD · Analysts' mean
EPS, year to Sep 2026
-0.87 · 1 analyst

Team and board

Officers

OfficerRole
Mitchell SteinerChairman, President, and Chief Executive Officer
Michele GrecoChief Financial Officer and Chief Administrative Officer
Philip GreenbergExecutive Vice President, General Counsel
Samuel FischExecutive Director, Investor Relations & Corporate Communications
Domingo RodriguezExecutive Vice President, Global Clinical Operations
Gary BirdExecutive Vice President, Quality and Regulatory Affairs
Kevin GilbertExecutive Vice President, Corporate Development
Harry Fisch
K. Gary BarnetteChief Scientific Officer

Board

DirectorRole
Mitchell SteinerChairman, President, and Chief Executive Officer
Grace S. HyunDirector
Harry Fisch
Loren KatzovitzDirector
Lucy LuDirector
Michael L. RankowitzDirector
Samuel FischExecutive Director, Investor Relations & Corporate Communications

Events

Next results
Dec 16, 2026 (expected)

Calls

CallWhenStatus
Veru (NASDAQ:VERU) Q3 2026 Earnings CallMon, Aug 10, 2026 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q2 2026 Earnings CallWed, May 13, 2026 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q1 2026 Earnings CallWed, Feb 04, 2026 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q4 2025 Earnings CallWed, Dec 17, 2025 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q3 2025 Earnings CallTue, Aug 12, 2025 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q2 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q1 2025 Earnings CallThu, Feb 13, 2025 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q3 2024 Earnings CallThu, Aug 08, 2024 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q2 2024 Earnings CallWed, May 08, 2024 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q1 2024 Earnings CallThu, Feb 08, 2024 · 8:00 AM ETReplay
All 19 calls
CallWhenStatus
Veru (NASDAQ:VERU) Q3 2023 Earnings CallThu, Aug 10, 2023 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q2 2023 Earnings CallThu, May 11, 2023 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q1 2023 Earnings CallThu, Feb 09, 2023 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q4 2022 Earnings CallMon, Dec 05, 2022 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q3 2022 Earnings CallThu, Aug 11, 2022 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q2 2022 Earnings CallThu, May 12, 2022 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q1 2022 Earnings CallWed, Feb 09, 2022 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q4 2021 Earnings CallThu, Dec 02, 2021 · 8:00 AM ETReplay
Veru (NASDAQ:VERU) Q4 2020 Earnings CallWed, Dec 09, 2020 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Aug 10, 2026 · Before open+18.9%
Q2 2026May 13, 2026 · Before open−0.4%
Q1 2026Feb 11, 2026 · Before open−0.4%
Q4 2025Dec 1, 2025−4.8%
Q3 2025Aug 12, 2025 · Before open−11.7%
Q2 2025May 8, 2025 · Before open+4.2%
Q1 2025Feb 13, 2025 · Before open−4.5%
Q4 2024Dec 5, 2024 · Before open−1.4%
Q3 2024Aug 8, 2024 · Before open+5.3%
Q2 2024Apr 1, 2024 · After close+1.9%
All 20 quarters
QuarterResultsShare move
Q1 2024Feb 14, 2024 · After close+0.7%
Q4 2023Dec 8, 2023 · After close−26.3%
Q3 2023Aug 10, 2023 · Before open+0.9%
Q2 2023May 11, 2023 · Before open−17.4%
Q1 2023Feb 9, 2023 · Before open−22.6%
Q4 2022Dec 5, 2022 · Before open+5.8%
Q3 2022Aug 11, 2022 · Before open+36.0%
Q2 2022May 12, 2022 · Before open+10.7%
Q1 2022Feb 9, 2022 · Before open+6.2%
Q4 2021Dec 2, 2021 · Before open+0.6%

Open Events

Decks

DeckKindSlidesDate
Obesity Week 2026Conference15 slidesNov 16, 2026
2026 Cantor Global Healthcare ConferenceConference59 slidesSeptember 2026
Q2 2026 Earnings PresentationEarnings8 slidesMay 13, 2026
4th Edition of World Obesity and Weight Management Congress 2024Conference34 slidesOct 24, 2024
2024 Cantor Global Healthcare ConferenceConference45 slidesSeptember 2024
Leerink Therapeutics Forum: I&I and Metabolism 2024Conference33 slidesJul 9, 2024
Jefferies Global Healthcare Conference 2024Conference27 slidesJun 5, 2024
GLP-1 Summit 2024Conference26 slidesMay 16, 2024
Oppenheimer 34th Annual Healthcare Life Sciences Conference 2024Conference26 slidesFeb 13, 2024
Investor Presentation (December 2023)Investor deck19 slidesDec 13, 2023
All 40 decks
DeckKindSlidesDate
IDWeek 2022Conference13 slidesOctober 2022
H.C. Wainwright 24th Annual Global Investment Conference 2022Conference45 slidesSep 12, 2022
Investor Presentation (July 2022)Investor deck46 slidesJuly 2022
Jefferies Healthcare Conference 2022Conference40 slidesJun 8, 2022
Investor Presentation (May 2022)Investor deck62 slidesMay 2022
H.C. Wainwright Global Investment Conference May 2022Conference36 slidesMay 2022
Oppenheimer 32nd Annual Healthcare Conference 2022Conference48 slidesMar 15, 2022
H.C. Wainwright BioConnect Conference 2022Conference45 slidesJan 10, 2022
Investor Presentation (January 2022)Investor deck59 slidesJanuary 2022
Investor Presentation (June 2021)Investor deck59 slidesJune 2021
Jefferies Virtual Healthcare Conference 2021Conference53 slidesJun 1, 2021
Oppenheimer 31st Annual Healthcare Conference 2021Conference64 slidesMar 16, 2021
Investor Presentation (January 2021)Investor deck66 slidesJanuary 2021
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit 2020Conference54 slidesSeptember 2020
Cantor Fitzgerald Global Healthcare Conference 2020Conference49 slidesSeptember 2020
Investor Presentation (June 2020)Investor deck47 slidesJune 2020
Investor Presentation (June 2020)Investor deck45 slidesJune 2020
Jefferies Healthcare Conference 2019Conference36 slidesJun 4, 2019
Oppenheimer Healthcare Conference 2019Conference37 slidesMarch 2019
2018 Cantor Fitzgerald Healthcare ConferenceConference24 slidesOctober 2018
HC Wainwright Healthcare Conference (September 2018)Conference30 slidesSep 6, 2018
Veru Healthcare — Investor Presentation (June 2017)Investor deck31 slidesJun 2, 2017
The Female Health Company — Investor Presentation (January 2017)Investor deck31 slidesJanuary 2017
Female Health — Investor Presentation (December 2016)Investor deck32 slidesDec 8, 2016
The Female Health Company — Investor Presentation (December 2016)Investor deck32 slidesDecember 2016
Female Health — Merger or Acquisition (June 2016)Merger or acquisition37 slidesJun 7, 2016
Female Health Company — Q1 2016 Earnings PresentationEarnings30 slidesJune 2016
The Female Health Company — Shareholder Meeting (June 2016)Shareholder meeting13 slidesJune 2016
The Female Health Company — Merger or Acquisition (April 2016)Merger or acquisition46 slidesApr 12, 2016
Female Health — Merger or Acquisition (April 2016)Merger or acquisition42 slidesApr 12, 2016

Open Decks

Financings

RaiseDate
Public offering of common stock (or pre-funded warrants) with accompanying Series A and Series B warrants
Closed: US$23.4M raised · US$3 a share · Canaccord Genuity LLC +1
Dealers: Canaccord Genuity LLC (co-lead), Oppenheimer & Co. Inc. (co-lead)
Use of proceeds: To start the Phase 2b PLATEAU clinical trial of enobosarm
Dec 17, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue16.9M16.3M39.4M61.3M42.6M31.8M15.9M13.7M22.1M
Cost of revenue11.0M8.73M8.76M13.3M11.8M10.1M7.09M6.64M8.78M
Gross profit5.85M7.57M30.6M47.9M30.8M21.7M8.77M7.02M13.3M
Research and development15.6M12.8M51.2M70.9M32.7M16.9M13.7M10.9M3.08M99.4K
Selling, general and administrative31.2M48.1M43.2M20.7M14.5M14.3M14.8M11.5M8.66M
Operating income-24.8M-36.2M-93.8M-83.5M13.0M-14.7M-6.44M-20.9M-8.49M3.02M
Depreciation and amortization152.1K268.2K269.9K138.0K98.0K146.0K176.8K334.0K422.9K
EBITDA-24.6M-35.9M-93.5M-83.4M13.1M-14.6M-20.7M-8.16M3.44M
Interest expense607.5K2.43M4.37M4.89M4.62M4.71M2.95M
Income before tax-92.7M-83.8M4.27M-20.1M-12.3M-23.1M-8.60M2.81M
Income tax00480.2K236.4K-3.13M-1.08M-303.9K866.1K-1.99M2.47M
Net income-22.7M-37.8M-93.2M-84.0M7.39M-19.0M-12.0M-23.9M-6.61M344.7K
Earnings per share, basic-1.55-2.80-1.10-1.050.10-0.28-0.19-0.44-0.250.01
Earnings per share, diluted-1.10-1.050.09-0.28-0.19-0.44-0.250.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents15.8M24.9M9.63M3.76M3.28M2.39M
Receivables3.96M4.51M3.55M8.79M5.23M5.02M3.97M3.42M10.8M
Inventory4.14M6.70M8.62M5.57M6.70M3.65M2.30M2.77M2.49M
Current assets18.9M35.2M22.9M104.0M151.8M27.0M16.8M11.2M10.3M16.3M
Property, plant and equipment364.8K481.4K1.65M1.19M592.6K312.7K351.9K404.6K555.5K825.1K
Goodwill6.88M6.88M6.88M6.88M6.88M6.88M6.88M6.88M6.88M
Total assets29.8M60.4M50.0M135.4M178.1M51.5M53.6M48.5M55.3M38.6M
Accounts payable3.12M2.26M12.9M22.0M3.41M2.81M3.12M3.23M2.69M701.0K
Current liabilities7.79M11.9M17.8M38.7M15.8M14.7M14.0M13.6M5.49M3.35M
Long-term debt1.75M
Total debt1.75M
Total liabilities11.5M28.1M30.3M52.6M25.9M21.4M21.3M19.0M6.88M4.69M
Shareholders' equity18.3M32.3M19.7M82.8M154.5M30.1M32.3M29.5M48.5M33.9M
Shares outstanding14.7M14.6M91.8M80.5M80.0M69.9M65.0M55.3M53.2M29.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-30.0M-21.7M-88.0M-47.5M-15.6M-1.93M-5.49M-11.5M982.9K-1.71M
Capital spending-1.08K-158.3K-665.7K-733.1K-376.6K-105.8K-108.5K-50.7K-133.5K-6.37K
Free cash flow-30.0M-21.8M-88.7M-48.2M-15.9M-2.04M-5.59M-11.6M849.4K-1.72M
Cash from investing25.1M146.2K6.33M4.27M14.6M-105.8K-108.5K-50.7K-90.4K-6.37K
Cash from financing-4.22M36.8M11.1M1.07M109.7M9.33M8.13M12.1M
Change in cash-9.12M15.3M-70.6M-42.2M108.8M7.29M2.54M481.9K892.5K-1.72M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportSep 8, 2026Current reportSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
8-K · Current reportAug 10, 2026ResultsSEC
8-K · Current reportJul 2, 2026Material contractSEC
424B5 · ProspectusJul 2, 2026Offer documentSEC
8-K · Current reportJun 4, 2026Current reportSEC
S-8 · Registration statement for employee plansMay 13, 2026Offer documentSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
8-K · Current reportMay 13, 2026ResultsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveApr 16, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 16, 2026Other filingsSEC
CORRESP · Letter to the SECApr 13, 2026Other filingsSEC
CORRESP · Letter to the SECApr 13, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 13, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 13, 2026Other filingsSEC
S-3 · Registration statementApr 7, 2026Offer documentSEC
S-3 · Registration statementApr 7, 2026Offer documentSEC
8-K · Current reportMar 13, 2026Management or board changeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
10-Q · Quarterly reportFeb 11, 2026Quarterly reportSEC
8-K · Current reportFeb 11, 2026ResultsSEC
DEFA14A · Additional proxy materialJan 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementJan 28, 2026Meeting noticeSEC
S-8 · Registration statement for employee plansDec 17, 2025Offer documentSEC
10-K · Annual reportDec 17, 2025Annual reportSEC
8-K · Current reportDec 17, 2025ResultsSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
8-K · Current reportOct 30, 2025Material contractSEC
424B5 · ProspectusOct 30, 2025Offer documentSEC
424B5 · ProspectusOct 29, 2025Offer documentSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
8-K · Current reportSep 26, 2025Current reportSEC
8-K · Current reportAug 27, 2025Current reportSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025Current reportSEC
8-K · Current reportAug 12, 2025ResultsSEC
8-K · Current reportJul 25, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 16, 2025Big-stake noticeSEC
DEFA14A · Additional proxy materialJul 15, 2025Meeting noticeSEC
DEFA14A · Additional proxy materialJun 10, 2025Meeting noticeSEC
DEF 14A · Proxy statementJun 10, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementMay 9, 2025Meeting noticeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
4 · Change in ownershipMay 8, 2025Insider tradeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
8-K · Current reportMar 14, 2025Management or board changeSEC
8-K · Current reportFeb 28, 2025Current reportSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 13, 2025Quarterly reportSEC
8-K · Current reportFeb 13, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
DEFA14A · Additional proxy materialJan 28, 2025Meeting noticeSEC
DEF 14A · Proxy statementJan 28, 2025Meeting noticeSEC
8-K · Current reportJan 3, 2025Acquisition or disposalSEC
EFFECT · Notice that a registration is effectiveDec 17, 2024Other filingsSEC
10-K · Annual reportDec 16, 2024Annual reportSEC
POS AM · Amendment to an effective registrationDec 12, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 8, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeOct 24, 2024Big-stake noticeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
8-K · Current reportSep 20, 2024Material contractSEC
8-K · Current reportAug 30, 2024Current reportSEC
8-K · Current reportAug 23, 2024Current reportSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2024Insider tradeSEC
8-K · Current reportAug 2, 2024Management or board changeSEC
8-K · Current reportJul 2, 2024Meeting outcomeSEC
8-K · Current reportJun 21, 2024Meeting outcomeSEC
DEFA14A · Additional proxy materialJun 20, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialJun 18, 2024Meeting noticeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
4 · Change in ownershipMay 24, 2024Insider tradeSEC
8-K · Current reportMay 22, 2024Current reportSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
DEFA14A · Additional proxy materialMay 9, 2024Meeting noticeSEC
DEFR14AMay 9, 2024Meeting noticeSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC
8-K · Current reportApr 26, 2024Material contractSEC
8-K · Current reportApr 25, 2024Current reportSEC
SC 13G · Big-stake noticeApr 24, 2024Big-stake noticeSEC
DEFA14A · Additional proxy materialApr 1, 2024Meeting noticeSEC
10-Q · Quarterly reportApr 1, 2024Quarterly reportSEC
10-K/A · Annual report, amendedApr 1, 2024Annual reportSEC
DEFA14A · Additional proxy materialMar 22, 2024Meeting noticeSEC
8-K · Current reportFeb 27, 2024Current reportSEC
NT 10-Q · Late filing noticeFeb 15, 2024Explanation requestSEC
8-K · Current reportFeb 15, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
8-K · Current reportFeb 8, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 6, 2024Big-stake noticeSEC
8-K · Current reportJan 26, 2024Current reportSEC
DEFA14A · Additional proxy materialJan 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementJan 26, 2024Meeting noticeSEC
SC 13G · Big-stake noticeDec 26, 2023Big-stake noticeSEC
8-K · Current reportDec 18, 2023Material contractSEC
424B5 · ProspectusDec 15, 2023Offer documentSEC
424B5 · ProspectusDec 13, 2023Offer documentSEC
424B5 · ProspectusDec 13, 2023Offer documentSEC
8-K · Current reportDec 13, 2023Material contractSEC
SC 13G/A · Big-stake notice, amendedDec 8, 2023Big-stake noticeSEC
10-K · Annual reportDec 8, 2023Annual reportSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
10-Q/A · Quarterly report, amendedNov 15, 2023Quarterly reportSEC
8-K · Current reportNov 15, 2023Current reportSEC
8-K · Current reportOct 2, 2023Material contractSEC
SC 13G/A · Big-stake notice, amendedSep 28, 2023Big-stake noticeSEC
8-K · Current reportSep 11, 2023Current reportSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 10, 2023ResultsSEC
8-K · Current reportJul 28, 2023Meeting outcomeSEC
DEFA14A · Additional proxy materialJun 12, 2023Meeting noticeSEC
DEF 14A · Proxy statementJun 12, 2023Meeting noticeSEC
SC 13G/A · Big-stake notice, amendedJun 8, 2023Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveMay 25, 2023Other filingsSEC
CORRESP · Letter to the SECMay 22, 2023Other filingsSEC
UPLOAD · Letter from the SECMay 19, 2023Other filingsSEC
PRE 14A · Preliminary proxy statementMay 15, 2023Meeting noticeSEC
S-3 · Registration statementMay 12, 2023Offer documentSEC
8-K · Current reportMay 12, 2023Material contractSEC
424B5 · ProspectusMay 12, 2023Offer documentSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
4 · Change in ownershipMay 11, 2023Insider tradeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC
8-K · Current reportMay 3, 2023Material contractSEC
424B5 · ProspectusMay 3, 2023Offer documentSEC
8-K · Current reportApr 20, 2023Acquisition or disposalSEC
SC 13G · Big-stake noticeApr 19, 2023Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveApr 17, 2023Other filingsSEC
CORRESP · Letter to the SECApr 13, 2023Other filingsSEC
8-K · Current reportApr 13, 2023Material contractSEC
8-K · Current reportApr 12, 2023Current reportSEC
S-3/A · Registration statement, amendedApr 11, 2023Offer documentSEC
CORRESP · Letter to the SECMar 31, 2023Other filingsSEC
8-K · Current reportMar 31, 2023Meeting outcomeSEC
UPLOAD · Letter from the SECMar 27, 2023Other filingsSEC
S-3 · Registration statementMar 16, 2023Offer documentSEC
8-K · Current reportMar 14, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
10-Q · Quarterly reportFeb 9, 2023Quarterly reportSEC
8-K · Current reportFeb 9, 2023ResultsSEC
DEFA14A · Additional proxy materialJan 27, 2023Meeting noticeSEC
DEF 14A · Proxy statementJan 27, 2023Meeting noticeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Veru Inc.’s releases · as of Aug 6, 2026

Common shares
17,050,320
Fully diluted
17,050,320

Fully diluted

LineSharesAs of
Common shares17,050,320Aug 6, 2026

Share count over time

CountShares
Aug 6, 202617,050,320

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard777K4.6%US$2.07MSep 30, 2026
Renaissance Technologies207K1.2%US$552KSep 30, 2026
Oppenheimer & Co Inc197K1.2%US$523KSep 30, 2026
Geode Capital194K1.1%US$517KSep 30, 2026
BlackRock165K0.97%US$438KSep 30, 2026
Summit Financial, LLC141K0.83%US$375KSep 30, 2026
Gsa Capital Partners LLP129K0.76%US$344KSep 30, 2026
Schonfeld Strategic Advisors LLC88,7980.52%US$236KSep 30, 2026
Raymond James Financial Inc81,8720.48%US$218KSep 30, 2026
Choreo, LLC74,8130.44%US$199KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
NewEdge Advisors, LLC60,7190.36%US$162KSep 30, 2026
Blair William & Co60,0000.35%US$160KSep 30, 2026
State Street55,0040.32%US$146KSep 30, 2026
Group One Trading LLC54,9550.32%US$146KSep 30, 2026
Two Sigma40,3740.24%US$107KSep 30, 2026
ADAR1 Capital Management, LLC35,0000.21%US$93,100Sep 30, 2026
Jane Street34,1770.20%US$90,911Sep 30, 2026
Northern Trust29,8090.17%US$79,292Sep 30, 2026
T. Rowe Price24,7650.15%US$66,000Sep 30, 2026
Quantinno Capital Management LP20,0000.12%US$53,200Sep 30, 2026
Susquehanna19,8720.12%US$52,860Sep 30, 2026
XTX Topco Ltd19,1960.11%US$51,061Sep 30, 2026
Osaic Holdings, Inc.16,1010.09%US$42,814Sep 30, 2026
Morgan Stanley12,6340.07%US$33,606Sep 30, 2026
Integrated Wealth Concepts LLC12,2900.07%US$32,691Sep 30, 2026
Axq Capital, LP10,7560.06%US$28,611Sep 30, 2026
Prime Capital Investment Advisors, LLC10,0000.06%US$26,600Sep 30, 2026
Northwestern Mutual Wealth Management Co10,0000.06%US$26,600Sep 30, 2026
Allworth Financial LP7,8170.05%US$20,794Sep 30, 2026
UBS3,6120.02%US$9,608Sep 30, 2026
Tower Research Capital LLC (TRC)1,8420.01%US$4,900Sep 30, 2026
JPMorgan1,249<0.01%US$3,197Sep 30, 2026
Chung Wu Investment Group, LLC1,000<0.01%US$2,660Sep 30, 2026
Strategic Investment Solutions, Inc.900<0.01%US$2,394Sep 30, 2026
Wells Fargo750<0.01%US$1,995Sep 30, 2026
Quent Capital, LLC688<0.01%US$1,830Sep 30, 2026
Rossby Financial, LCC600<0.01%US$1,596Sep 30, 2026
SBI Securities Co., Ltd.418<0.01%US$1,112Sep 30, 2026
Signaturefd, LLC300<0.01%US$797Sep 30, 2026
Axiom Investment Management LLC250<0.01%US$665Sep 30, 2026
Caitong International Asset Management Co., Ltd228<0.01%US$606Sep 30, 2026
Harbour Investments, Inc.200<0.01%US$532Sep 30, 2026
Rockefeller Capital Management L.P.200<0.01%US$532Sep 30, 2026
PlanVest Financial, Inc174<0.01%US$463Sep 30, 2026
Farther Finance Advisors, LLC130<0.01%US$346Sep 30, 2026
Trust Co Of Toledo NA100<0.01%US$266Sep 30, 2026
Lodestone Wealth Management LLC100<0.01%US$266Sep 30, 2026
Marshall & Sterling Wealth Advisors Inc.95<0.01%US$253Sep 30, 2026
Jones Financial Companies Lllp60<0.01%US$152Sep 30, 2026
Robinhood Markets, Inc.26<0.01%US$68Sep 30, 2026

This page holds 50 of 54 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund532K3.1%US$1.66MJun 30, 2026
Vanguard Extended Market Index Fund158K0.93%US$495KJun 30, 2026
Fidelity Extended Market Index Fund91,9000.54%US$218KMay 31, 2026
iShares Micro-Cap ETF49,5740.29%US$155KJun 30, 2026
Fidelity Total Market Index Fund23,0360.14%US$54,595May 31, 2026
Fidelity Series Total Market Index Fund20,9690.12%US$49,697May 31, 2026
Fidelity Nasdaq Composite Index Fund8,5190.05%US$20,190May 31, 2026
Vanguard Balanced Index Fund8,3340.05%US$26,085Jun 30, 2026
Schwab Total Stock Market Index Fund6,5000.04%US$14,560Jul 31, 2026
1290 VT Micro Cap Portfolio3,3440.02%US$10,467Jun 30, 2026

Insider trades

TradeTradeSharesPriceValueDate
Barnette K Gary
Officer: Chief Scientific Officer
Buy1,800USD 2.69US$4,842Aug 13, 2026

Big stakes

StakeStakeSharesDateFiling
Alyeska Investment Group, L.P.9.90%1.59MDec 31, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lucy Lu
Other companies: Fortress Biotech, Inc. (Director · Dec 14, 2022 – Jan 1, 2025 · Past)
Director · Since at least Nov 2, 2022
Michael L. Rankowitz
Other companies: Carlyle Secured Lending, Inc. (Director · Apr 12, 2013 – Apr 12, 2013 · Past)
Director · Since at least Mar 20, 2018
Domingo RodriguezExecutive Vice President, Global Clinical Operations · Since at least Nov 5, 2026
Donna FelchDirector · Feb 2, 2006 – Oct 31, 2016 · Past
Gary BirdExecutive Vice President, Quality and Regulatory Affairs · Since at least Nov 5, 2026
Grace S. HyunDirector · Since at least Aug 11, 2020
Harry FischChief Corporate Officer, Director · Since at least Apr 22, 2022
Harry FischDirector · Since at least Nov 4, 2026
Karen Louise KingPresident and CEO, Director · Jan 20, 2014 – Feb 5, 2015 · Past
Kevin GilbertExecutive Vice President, Corporate Development · Since at least Nov 5, 2026
All 20 people
PersonSeat
K. Gary BarnetteChief Scientific Officer · Since at least Jan 27, 2025
Loren M. KatzovitzDirector · Since at least Aug 1, 2024
Michele GrecoChief Financial Officer and Chief Administrative Officer · Since at least Sep 30, 2015
Mitchell S. SteinerChairman, President, and Chief Executive Officer · Since at least Sep 8, 2026
Philip GreenbergExecutive Vice President, General Counsel · Since at least Nov 5, 2026
Richard E WenningerDirector · Dec 8, 2011 – Dec 9, 2014 · Past
Robert GetzenbergChief Scientific Officer · Mar 20, 2018 – May 2, 2018 · Past
Samuel FischExecutive Director, Investor Relations & Corporate Communications · Since at least Sep 8, 2026
Stephen M DearholtDirector · Jan 4, 2012 – Jan 16, 2015 · Past
William R Gargiulo JrDirector · May 23, 2016 – May 23, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Veru Inc.